What is the normal aldosterone-to-cortisol ratio in adrenal vein sampling?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Aldosterone-to-Cortisol Ratio Interpretation in Adrenal Vein Sampling

The interpretation of aldosterone-to-cortisol ratios in adrenal vein sampling depends critically on whether cosyntropin stimulation is used, with different cutoff values for lateralization: >4:1 with cosyntropin stimulation indicates unilateral disease, while >2:1 without cosyntropin suggests unilateral disease.

Protocol-Dependent Interpretation

The aldosterone-to-cortisol ratio thresholds vary based on your AVS protocol 1:

With Continuous Cosyntropin Stimulation

  • Lateralization index (high-side to low-side) >4:1 = unilateral aldosterone excess
  • Lateralization index <3:1 = bilateral aldosterone hypersecretion
  • Lateralization index 3:1-4:1 = indeterminate (may be either unilateral or bilateral disease)

These cutoffs achieve 95% sensitivity and 100% specificity for detecting unilateral aldosterone hypersecretion 1.

Without Cosyntropin Stimulation

  • Lateralization index >2:1 = consistent with unilateral disease 1
  • Some centers use an alternative approach: comparing adrenal vein aldosterone-cortisol ratios to peripheral vein samples

Alternative Peripheral Comparison Method

When comparing to peripheral venous samples 1:

  • Adrenal vein A/C ratio ≥2.5 times peripheral on one side, AND
  • Contralateral adrenal vein A/C ratio no higher than peripheral (indicating contralateral suppression)
  • This pattern indicates lateralization and suggests unilateral adrenalectomy will improve outcomes

Confirming Successful Sampling (Selectivity Index)

Before interpreting lateralization ratios, you must confirm adequate adrenal vein catheterization 2:

  • With cosyntropin: adrenal vein-to-IVC cortisol ratio >5:1
  • Without cosyntropin: adrenal vein-to-IVC cortisol ratio >1.4-3.0

Critical Caveats

The "gray zone" (3:1-4:1 with cosyntropin) requires cautious interpretation 1. These patients may have either unilateral or bilateral disease. You must integrate:

  • Clinical presentation
  • CT/MRI findings
  • Contralateral suppression data
  • Consider repeat AVS if surgical decision remains unclear

Cosyntropin controversy: While cosyntropin improves selectivity indices and reduces technical failures 3, it may cause discordance in lateralization interpretation. Studies show 19% discordance rates between pre- and post-cosyntropin results, with 64% of discordant cases showing apparent unilateral disease becoming bilateral after cosyntropin 2. However, most studies find no difference in post-adrenalectomy outcomes regardless of cosyntropin use 2.

French consensus recommends a lateralization cutoff of ≥4:1 for simultaneous bilateral sampling without ACTH stimulation 4, emphasizing the importance of institutional protocols.

Practical Algorithm

  1. Verify selectivity first - ensure adequate catheterization using cortisol gradients
  2. Calculate cortisol-corrected aldosterone ratios for both adrenal veins
  3. Apply protocol-specific cutoffs:
    • Cosyntropin protocol: >4:1 = unilateral; <3:1 = bilateral
    • Non-stimulated protocol: >2:1 = unilateral
  4. For indeterminate results (3:1-4:1): assess contralateral suppression and correlate with imaging
  5. Consider repeat AVS if results don't align with clinical picture or imaging 5, 6

The most recent 2025 Endocrine Society guideline 2 maintains these established cutoffs while emphasizing that institutions should develop expertise with their chosen protocol rather than switching between methods.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.